INTRODUCTION

Peginterferon alfa-2a (brand name Pegasys) is a recombinant human interferon that is used to treat hepatitis C and hepatitis B viruses by stimulating the innate antiviral responses.

This plasmid is designed for expressing Peginterferon alfa-2a in E.coli expression system.

PRODUCT INFORMATION

Item No.: PPBD-143
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Peginterferon alfa-2a
Brand Name(s): Pegasys
Classification: Interferons
Amino Acid Sequence: Identical to DB00008

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

[1] Bagaglio S, Uberti-Foppa C, Morsica G. Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use. Drugs. 2017 Jul;77(10):1043-1055.

[2] Myers RP, Shah H, Burak KW, Cooper C, Feld JJ. An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol Hepatol. 2015 Jan-Feb;29(1):19-34.

Contact Us